Family lifestyle program may delay early puberty in at-risk girls

NCT ID NCT07460544

Not yet recruiting Disease control Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a family-based weight management program can slow the start of puberty in girls aged 6.5 to 8 years who have overweight or obesity. Half of the 240 girls will join a 20-session program focused on healthy eating and activity, while the other half receive usual care. Researchers will track puberty signs over 3 years to see if the program makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Family-Based Treatment (FBT) - a behavioral program focusing on healthy eating and physical activity
What this could lead to: If successful, this approach could help delay early puberty in girls with higher weight, potentially reducing risks for later health problems like heart disease and mental health issues.
What could go wrong: This is an early-stage study with 240 participants, so results may not apply to all girls. The program requires a big time commitment, and it's unclear if benefits will last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOMETABOLIC HEALTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Health Behavior Obesity obesity disorder Overweight Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOMETABOLIC HEALTH HEALTH BEHAVIOR OVERWEIGHT , OBESITY PUBERTY

Contacts and locations

Locations

University of Washington

Seattle, Washington, 98195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.